A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Apixaban Impurity 97 - Request Quote

Picture of Apixaban Impurity 97

Apixaban Impurity 97

SZ CAT No:SZ-A062208
CAS No
NA
Mol.F.
C29H33N5O6
Mol.Wt.
547.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

CHNS Ratio (%) :

Usage Note:

Apixaban Impurity 97 is chemically 1-(4-Methoxyphenyl)-7a-morpholino-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-3a,4,5,6,7,7a-hexahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid. Apixaban Impurity 97 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 97 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Apixaban Impurity 97

Purchase Apixaban Impurity 97

Apixaban Impurity 97 suppliers

Apixaban Impurity 97 manufacturers

Apixaban Impurity 97 price

Order Apixaban Impurity 97

Enquire Apixaban Impurity 97

Apixaban Impurity 97 cost

Apixaban Impurity 97 Supplier

Apixaban Impurity 97 Distributor

Apixaban Impurity 97 for Method Validation

Apixaban Reference Standard

Apixaban Impurity 97 for ANDA Filing

Apixaban Impurity 97 for Forced Degradation Studies

Apixaban Impurity 97 Identification Standards

Apixaban Impurity 97 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.